← Back to headlines
BioSyent Releases Q2 and H1 2026 Financial Results
BioSyent has released its financial results for the second quarter and first half of 2026.
20 Aug, 21:00 — 20 Aug, 21:00
Sources
Showing 1 of 1 sources
Related Stories
Moderna Raises $2 Billion via Convertible Notes for Cancer Vaccine Development
44m ago
Best Buy Raises Annual Outlook on Strong Electronics Demand
49m ago
Enbridge Partners with KKR and Apollo for C$2.7 Billion Pipeline Investment
59m ago
American Airlines Expands Transatlantic Network With New European Routes
1h ago